Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NPY1R | P25929 | 7/20 | 0.43 |
| ▸ | NPY4R | P50391 | 7/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.43 |
| ▸ | NPY2R | P49146 | 4/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.41 |
| ▸ | CAD | P27708 | 1/20 | 0.39 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18465137 | 0.90 | NPY4R (0.43) | KMT2APOLBNPY1RNPY4RNPY5R | |
| SCHEMBL21879811 | 0.89 | KMT2A (0.42) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL5812127 | 0.87 | SIRT6 (0.43) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL5812133 | 0.87 | SIRT6 (0.43) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL13261943 | 0.86 | NOD1 (0.58) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL1541677 | 0.86 | NOD1 (0.58) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL4522102 | 0.86 | NOD1 (0.58) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL21842547 | 0.86 | NOD1 (0.58) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL7651136 | 0.86 | NOD1 (0.58) | KMT2APOLBL3MBTL1NPY1RNPY4R | |
| SCHEMBL359000 | 0.86 | NOD1 (0.58) | KMT2APOLBL3MBTL1NPY1RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265039-A1 | METHOD FOR PRODUCING ESTER BASED ON ECO-FRIENDLY AND HIGH-EFFICIENCY ESTERIFICATION BY USING BASE EXCHANGE OF SALT AND THE COMPOUND THEREOF | WOODWARD BIO CORP. (KR) | 2023-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265039-A1 | METHOD FOR PRODUCING ESTER BASED ON ECO-FRIENDLY AND HIGH-EFFICIENCY ESTERIFICATION BY USING BASE EXCHANGE OF SALT AND THE COMPOUND THEREOF | SLC6A9, TST, SLC6A5 | KMT2A 2581/4885POLB 1871/4885L3MBTL1 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.